Core Viewpoint - Guoyi Quantum's IPO application has been accepted, aiming to raise 1.169 billion yuan for projects focused on high-end scientific instrument industrialization, quantum technology research institute construction, and application center network development, all centered around its main business in scientific instruments [1][2]. Group 1: Company Mission and Product Offerings - Guoyi Quantum is committed to the mission of "creating instruments for the country," focusing on the independent research and industrialization of high-end scientific instruments [5]. - The company's product range includes electronic paramagnetic resonance spectrometers, scanning NV probe microscopes, field emission scanning electron microscopes (SEM), and focused ion beam electron beam dual beam microscopes (FIB-SEM), breaking the monopoly of international instrument giants in several niche areas [5]. - The electronic microscope series has become a significant revenue driver, with projected sales revenue of 246 million yuan in 2024, accounting for 50.80% of total revenue, indicating that domestic electron microscopes can compete with international brands [5]. Group 2: Financial Performance and Growth - The company has experienced rapid revenue growth, with figures rising from 151 million yuan in 2022 to 399 million yuan in 2023, and projected to reach 501 million yuan in 2024, resulting in a compound annual growth rate of 81.94% over the past three years [8]. - Despite the revenue growth, the company has not yet achieved profitability due to ongoing high levels of R&D and market investment, with R&D expenses accounting for 75.34% of revenue in 2022 and 23.13% in 2024 [8]. - As of the end of 2024, the company will have a research and development staff ratio of 31.28% and has been granted 129 authorized invention patents, contributing to the establishment of national standards in the field of quantum measurement [8]. Group 3: Fundraising and Strategic Focus - The IPO funds will be allocated to three main projects: - High-end scientific instrument industrialization project to expand existing product capacity and promote new product launches, solidifying its industrial advantages in electron microscopes and quantum measurement [9]. - Quantum technology development research institute construction project to enhance cutting-edge technology research in quantum sensing and precision measurement, maintaining technological leadership [9]. - Application center network construction project to establish domestic and international demonstration, testing, and service centers, improving customer support capabilities and brand influence, and accelerating global market expansion [9]. Group 4: Market Position and Future Outlook - In a global scientific instrument market dominated by international giants like Thermo Fisher, Danaher, and Ametek, Guoyi Quantum is gradually making inroads in strategic areas such as electron microscopy and quantum precision measurement through independent innovation [11]. - Successfully listing on the Sci-Tech Innovation Board will provide strong support for subsequent R&D expansion and market development, injecting new momentum into China's path toward self-sufficiency in high-end scientific instruments [11].

本次募集资金投资项目经 2025 年第三次临时股东会确定，由董事会负责实施，主要用于投资如下项 目： | | | 智通财经APP获悉，12月10日，国仪量子技术（合肥）股份有限公司(简称：国仪量子)上交所科创板 IPO已受理。华泰联合证券为保荐机构，拟募资11.69亿元。 招股书显示，国仪量子自成立以来专注于高端科学仪器的研发，面向量子科技、材料科学、化学化工、 生物医药、先进制造等多个领域，向全球范围内的高校及科研院所、企业提供科技前沿探索所需的高端 科学仪器装备、以增强型量子传感器为代表的核心关键器件以及解决方案，积极为解决"卡脖子"问题贡 献力量。 从全球范围来看，科学仪器市场呈现高度集中化趋势，欧美企业凭借技术积累和品牌优势占据主导地 位，尤其是在高精度、高复杂度的高端仪器领域，国际巨头几乎呈垄断态势。随着国家对科技创新和高 端制造的高度重视，以及下游生物医药、半导体、新材料等产业的快速发展，国内高端科学仪器需求持 续增长，但国产化率仍然较低，进口依赖度较高，国产企业正通过技术突破和产品升级逐步缩小与国际 巨头的差距。 国仪量子自成立以来积极参与国内乃至国际市场竞争，推出的电子顺磁共振波谱仪、扫描 N ...